Results 61 to 70 of about 148 (100)

An Amazing 30-Year Journey around the DABO Family: A Medicinal Chemistry Lesson on a Versatile Class of Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors. [PDF]

J Med Chem
Fabbrizi E, Chernyshov VV, Fiorentino F, Sbardella G, Ragno R, Nawrozkij M, Ivanov R, Rotili D, Mai A.   +8 more
europepmc   +1 more source

Focus on Chirality of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors. [PDF]

Molecules, 2016
Famiglini V, Silvestri R.
europepmc   +1 more source

Development of diarylpyrimidine derivatives (& other heterocycles) as HIV-1 and WT RT inhibitors. [PDF]

RSC Med Chem
Dorababu A.
europepmc   +1 more source

Molecular Docking Studies of HIV-1 Resistance to Reverse Transcriptase Inhibitors: Mini-Review. [PDF]

Molecules, 2018
Tarasova O, Poroikov V, Veselovsky A.
europepmc   +1 more source

Structure-based design and optimization lead to the identification of novel dihydrothiopyrano[3,2-d]pyrimidine derivatives as potent HIV-1 inhibitors against drug-resistant variants. [PDF]

Acta Pharm Sin B
Wang Z, Zhang H, Gao Z, Sang Z, De Clercq E, Pannecouque C, Kang D, Zhan P, Liu X.   +8 more
europepmc   +1 more source

Pyrimidine 2,4-Diones in the Design of New HIV RT Inhibitors. [PDF]

Molecules, 2019
Romeo R, Iannazzo D, Veltri L, Gabriele B, Macchi B, Frezza C, Marino-Merlo F, Giofrè SV.   +7 more
europepmc   +1 more source

NMR characterization of HIV-1 reverse transcriptase binding to various non-nucleoside reverse transcriptase inhibitors with different activities. [PDF]

Sci Rep, 2015
Thammaporn R, Yagi-Utsumi M, Yamaguchi T, Boonsri P, Saparpakorn P, Choowongkomon K, Techasakul S, Kato K, Hannongbua S.   +8 more
europepmc   +1 more source

Development of enhanced HIV-1 non-nucleoside reverse transcriptase inhibitors with improved resistance and pharmacokinetic profiles. [PDF]

Sci Adv
Wang Z, Rumrill S, Kang D, Guma SD, Feng D, De Clercq E, Pannecouque C, Chen CH, Arnold E, Ruiz FX, Liu X, Zhan P.   +11 more
europepmc   +1 more source

Design, synthesis, and evaluation of diarylpyridines and diarylanilines as potent non-nucleoside HIV-1 reverse transcriptase inhibitors. [PDF]

J Med Chem, 2010
Tian X, Qin B, Wu Z, Wang X, Lu H, Morris-Natschke SL, Chen CH, Jiang S, Lee KH, Xie L.   +9 more
europepmc   +1 more source

Structure-based evaluation of non-nucleoside inhibitors with improved potency and solubility that target HIV reverse transcriptase variants. [PDF]

J Med Chem, 2015
Frey KM, Puleo DE, Spasov KA, Bollini M, Jorgensen WL, Anderson KS.   +5 more
europepmc   +1 more source